Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients
Clinical trial NCT03528421 · UNKNOWN
Trial details
- NCT number
- NCT03528421
- Sponsor
- Beijing Immunochina Medical Science & Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-22
- Primary completion
- 2020-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.